Picton Mahoney Asset Management’s CERo Therapeutics CERO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-75
Closed -$1.5M 772
2022
Q2
$1.5M Hold
75
0.06% 441
2022
Q1
$1.5M Buy
+75
New +$1.5M 0.05% 463